Dr. Mothaffar F. Rimawi M.D.
Hematologist-Oncologist | Hematology & Oncology
6620 Main St Breast Center, Suite Houston TX, 77030Rating
4/5
About
Dr. Mothaffar Rimawi is a hematologist oncologist practicing in Houston, TX. Dr. Rimawi specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Faculty of Medicine (Amman, Jordan) MD 1997
University of Jordan Faculty of Medicine 1997
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.
- High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
- β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
- Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.
- Breast Cancer: Blocking both driver and escape pathways improves outcomes.
- Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
- Predictors of post-mastectomy reconstruction in an underserved population.
- Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.
- Aromatase inhibitor adverse effects: are we sweeping them under the rug?
- Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
- A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer.
- Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
- Targeting HER2 for the treatment of breast cancer.
- Resistance to Anti-HER2 Therapies in Breast Cancer.
- Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.
Clinical Trials
- Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
- Ruxolitinib for Premalignant Breast Disease
- Phase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
- Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
- High Dose Vitamin D vs Standard Dose Vitamin D Study
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- NSABP Biospecimen Discovery Project
Treatments
- Breast Cancer, Brain Tumor, Breast Biopsy
- Breast Cancer
Dr. Mothaffar F. Rimawi M.D.'s Practice location
Mothaffar Rimawi
6620 Main St Breast Center, Suite -Houston, TX 77030Get Direction
Dr. Mothaffar F. Rimawi M.D.'s reviews
Write ReviewPatient Experience with Dr. Rimawi
Recommended Articles
![]()
'Robocop' Stem Cells Developed to Fight CancerCancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
![]()
The Blow Self-Image Can Take During Lymphoma TreatmentMany who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...
![]()
Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of ChemoIn some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...
![]()
Dreams Do Come True: 9-year-old Baseball Fanatic Signed Onto TeamLike most young baseball fans, John “Parker” Staples' room is covered in memorabilia from his favorite team, the Washington Nationals, but unlike most kids, Parker's room is at the University of Virginia Children's Hospital.John “Parker” Staples, is nine-year old who was diagnosed with...
![]()
Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin LymphomaAbby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...
![]()
This New Zealand Native Beat Cancer Eight TimesBeing diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
Nearby Providers
![]()
Mr. Amir Rasheed M.D.13111 E Freeway Houston TX 77015![]()
Dr. Mohamed Haq MD11950 Old Galveston Rd Houston TX 77034![]()
Dr. Sahba Q Nadeem MD11914 Astoria Blvd Houston TX 77089![]()
Dr. Yuval Raizen MD2130 W Holcombe Blvd Houston TX 77030![]()
Dr. Charles L Conlon MD16675 Southwest Fwy Sugar Land TX 77479![]()
Dr. Jorge German Darcourt M.D.16675 Southwest Fwy Sugar Land TX 77479
Nearest Hospitals
TEXAS CHILDRENS HOSPl
6621 FANNIN STREET HOUSTON TX 77030CHI ST LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEl
6720 BERTNER HOUSTON TX 77030METHODIST HOSPITAL,THEl
6565 FANNIN HOUSTON TX 77030